Implementing process intensification in advanced therapy manufacturing

Adopting process intensification requires rethinking traditional production workflows to achieve greater output and robustness without compromising product quality. This discussion brings together experts to examine implementation frameworks, enabling technologies, and real-world outcomes that demonstrate the value of intensified processes in cell and gene therapy manufacturing. 

Key takeaways:

• Define key principles and goals of process intensification in advanced therapies 

• Assess upstream and downstream approaches that improve throughput and yield 

• Discuss how continuous and closed systems support intensified manufacturing 

• Evaluate the impact of automation and digital monitoring on process control 

• Review practical considerations for facility design and regulatory alignment